Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0DN0W
|
||||
| Drug Name |
Niraparib Tosylate
|
||||
| Synonyms |
Zejula
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Recurrent epithelial ovarian or primary peritoneal cancer [ICD10:C78] | Approved | [889446] | ||
| Company |
Tesaro
|
||||
| Target and Pathway | |||||
| Target(s) | Poly [ADP-ribose] polymerase-1 | Target Info | Modulator | [556264] | |
| KEGG Pathway | Base excision repair | ||||
| NF-kappa B signaling pathway | |||||
| PANTHER Pathway | FAS signaling pathway | ||||
| Pathway Interaction Database | Integrin-linked kinase signaling | ||||
| Caspase Cascade in Apoptosis | |||||
| Notch-mediated HES/HEY network | |||||
| Reactome | Dual Incision in GG-NER | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

